Narinder Pal Bhalla insider trades
Open-market stock purchases and sales by Narinder Pal Bhalla, Chief Medical Officer at Lexeo Therapeutics, Inc, from SEC Form 4 filings since Feb 13, 2026.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 24, 2026 | LXEO Lexeo Therapeutics, Inc | Bought (not open market) | — |
| Sep 14, 2026 | LXEO Lexeo Therapeutics, Inc | Bought (not open market) | $9.7K |
| Jul 1, 2026 | LXEO Lexeo Therapeutics, Inc | Sold | $98.6K |
| Jun 29, 2026 | LXEO Lexeo Therapeutics, Inc | Bought (not open market) | — |
| Feb 13, 2026 | LXEO Lexeo Therapeutics, Inc | Bought (not open market) | — |
| Feb 13, 2026 | LXEO Lexeo Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- LXEO Lexeo Therapeutics, Inc: 1 sale, last Sep 24, 2026
Get free alerts when Narinder Pal Bhalla files a new trade →